Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Frank van de Veerdonk and Mihai Netea.
Connection Strength

6.599
  1. Rare variants increase the risk of severe COVID-19. Elife. 2021 Mar 23; 10.
    View in: PubMed
    Score: 0.936
  2. Blocking IL-1 to prevent respiratory failure in COVID-19. Crit Care. 2020 07 18; 24(1):445.
    View in: PubMed
    Score: 0.893
  3. Personalized medicine in influenza: a bridge too far or the near future? Curr Opin Pulm Med. 2017 05; 23(3):237-240.
    View in: PubMed
    Score: 0.715
  4. COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion. Lancet Respir Med. 2021 07; 9(7):795-802.
    View in: PubMed
    Score: 0.237
  5. Invasive pulmonary aspergillosis associated with viral pneumonitis. Curr Opin Microbiol. 2021 08; 62:21-27.
    View in: PubMed
    Score: 0.237
  6. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19. J Infect Dis. 2021 04 23; 223(8):1322-1333.
    View in: PubMed
    Score: 0.235
  7. Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort Study. Cell Rep Med. 2020 08 25; 1(5):100073.
    View in: PubMed
    Score: 0.224
  8. Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19. JAMA Netw Open. 2020 08 03; 3(8):e2017708.
    View in: PubMed
    Score: 0.224
  9. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection. Cell. 2020 05 28; 181(5):969-977.
    View in: PubMed
    Score: 0.220
  10. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife. 2020 04 27; 9.
    View in: PubMed
    Score: 0.220
  11. Antifungal immune responses: emerging host-pathogen interactions and translational implications. Genome Med. 2018 05 25; 10(1):39.
    View in: PubMed
    Score: 0.192
  12. Metabolic Induction of Trained Immunity through the Mevalonate Pathway. Cell. 2018 01 11; 172(1-2):135-146.e9.
    View in: PubMed
    Score: 0.187
  13. Are histones real pathogenic agents in sepsis? Nat Rev Immunol. 2018 02; 18(2):148.
    View in: PubMed
    Score: 0.187
  14. Rewiring monocyte glucose metabolism via C-type lectin signaling protects against disseminated candidiasis. PLoS Pathog. 2017 Sep; 13(9):e1006632.
    View in: PubMed
    Score: 0.183
  15. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017 Jul; 17(7):407-420.
    View in: PubMed
    Score: 0.178
  16. Adjuvant interferon-gamma immunotherapy in a patient with progressive cerebral Nocardia abscesses. Int J Infect Dis. 2017 Jun; 59:25-28.
    View in: PubMed
    Score: 0.177
  17. MST1R mutation as a genetic cause of Lady Windermere syndrome. Eur Respir J. 2017 01; 49(1).
    View in: PubMed
    Score: 0.175
  18. Pattern recognition receptors and their role in invasive aspergillosis. Ann N Y Acad Sci. 2012 Dec; 1273:60-7.
    View in: PubMed
    Score: 0.132
  19. The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis. Eur J Immunol. 2011 Aug; 41(8):2260-8.
    View in: PubMed
    Score: 0.119
  20. Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19. Biosci Rep. 2021 07 30; 41(7).
    View in: PubMed
    Score: 0.060
  21. The Association of TSH and Thyroid Hormones With Lymphopenia in Bacterial Sepsis and COVID-19. J Clin Endocrinol Metab. 2021 06 16; 106(7):1994-2009.
    View in: PubMed
    Score: 0.059
  22. A limited role of cytokine storm and fibrogenesis in COVID-19 related liver injury. J Gastrointestin Liver Dis. 2021 03 13; 30(1):166-168.
    View in: PubMed
    Score: 0.058
  23. Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes. J Infect Dis. 2021 02 03; 223(2):214-224.
    View in: PubMed
    Score: 0.058
  24. A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients. Int J Obes (Lond). 2021 03; 45(3):687-694.
    View in: PubMed
    Score: 0.058
  25. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome Med. 2021 01 13; 13(1):7.
    View in: PubMed
    Score: 0.058
  26. Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study. Crit Care. 2020 12 10; 24(1):688.
    View in: PubMed
    Score: 0.057
  27. Increased Plasma Heparanase Activity in COVID-19 Patients. Front Immunol. 2020; 11:575047.
    View in: PubMed
    Score: 0.057
  28. Presence of Genetic Variants Among Young Men With Severe COVID-19. JAMA. 2020 08 18; 324(7):663-673.
    View in: PubMed
    Score: 0.056
  29. Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis. Cell Host Microbe. 2020 07 08; 28(1):117-123.e1.
    View in: PubMed
    Score: 0.055
  30. A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans. J Infect Dis. 2019 07 31; 220(5):862-872.
    View in: PubMed
    Score: 0.052
  31. Host Genetic Signatures of Susceptibility to Fungal Disease. Curr Top Microbiol Immunol. 2019; 422:237-263.
    View in: PubMed
    Score: 0.050
  32. Development of Endotoxin Tolerance Does Not Influence the Response to a Challenge with the Mucosal Live-Attenuated Influenza Vaccine in Humans In Vivo. Front Immunol. 2017; 8:1600.
    View in: PubMed
    Score: 0.047
  33. Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease. Open Forum Infect Dis. 2017; 4(4):ofx202.
    View in: PubMed
    Score: 0.046
  34. An integrative genomics approach identifies novel pathways that influence candidaemia susceptibility. PLoS One. 2017; 12(7):e0180824.
    View in: PubMed
    Score: 0.045
  35. Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway. Proc Natl Acad Sci U S A. 2017 05 23; 114(21):5485-5490.
    View in: PubMed
    Score: 0.045
  36. Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1ß and by the induction of endogenous IL-1Ra. Ann Rheum Dis. 2016 06; 75(6):1219-27.
    View in: PubMed
    Score: 0.039
  37. Receptor recognition of and immune intracellular pathways for Veillonella parvula lipopolysaccharide. Clin Vaccine Immunol. 2009 Dec; 16(12):1804-9.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.